Cargando…

International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?

A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characterized by single or few detectable metastatic lesions. The existing treatment guidelines for patients with localized MBC include surgery, radiotherapy, and regional chemotherapy. The European School of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagani, Olivia, Senkus, Elżbieta, Wood, William, Colleoni, Marco, Cufer, Tanja, Kyriakides, Stella, Costa, Alberto, Winer, Eric P., Cardoso, Fatima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298957/ https://www.ncbi.nlm.nih.gov/pubmed/20220104 http://dx.doi.org/10.1093/jnci/djq029

Ejemplares similares

International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
por: Cardoso, Fatima, et al.
Publicado: (2009)

Cure in metastatic breast cancer
por: Westphal, Theresa, et al.
Publicado: (2018)

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic
por: Curigliano, Giuseppe, et al.
Publicado: (2020)

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)
por: Cardoso, F., et al.
Publicado: (2014)

SEOM clinical guidelines in metastatic breast cancer 2015
por: Gavilá, J., et al.
Publicado: (2015)

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer
por: Aapro, Matti, et al.
Publicado: (2022)

New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology
por: Senkus, Elżbieta
Publicado: (2017)

Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer
por: Montagna, Emilia, et al.
Publicado: (2019)

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
por: Stanowicka-Grada, Malwina, et al.
Publicado: (2023)

Metastatic rectal cancer to the breast
por: Li, Hsiao C, et al.
Publicado: (2009)

Pertuzumab in Metastatic Breast Cancer
por: Patel, Rachana, et al.
Publicado: (2012)

Case report: Metastatic metaplastic breast cancer with choriocarinomatous features: Targeting the choriocarcinoma component for cure
por: Mehta, Krisha K., et al.
Publicado: (2023)

Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16–20 March 2004
por: Senkus-Konefka, Elżbieta, et al.
Publicado: (2004)

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
por: Lobbezoo, D J A, et al.
Publicado: (2015)

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
por: Orlando, Laura, et al.
Publicado: (2006)

Can we cure metastatic EGFR-mutated lung cancer today?
por: Christopoulos, Petros
Publicado: (2023)

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
por: Cardoso, Maria-Joao, et al.
Publicado: (2021)

Corynebacterium parvum and metastatic breast cancer.
por: Haskell, C. M., et al.
Publicado: (1982)

Taxanes for the Treatment of Metastatic Breast Cancer
por: Gradishar, W.J.
Publicado: (2012)

Everolimus in the Treatment of Metastatic Breast Cancer
por: Royce, Melanie E, et al.
Publicado: (2015)

The AURORA initiative for metastatic breast cancer
por: Zardavas, D, et al.
Publicado: (2014)

Oral vinorelbine in metastatic breast cancer
por: Conte, PF, et al.
Publicado: (2005)

HUNK Signaling in Metastatic Breast Cancer
por: Dilday, Tinslee, et al.
Publicado: (2020)

Imaging diagnosis of metastatic breast cancer
por: Pesapane, Filippo, et al.
Publicado: (2020)

Hydronephrosis Caused by Metastatic Breast Cancer
por: Sugimoto, Hitoshi, et al.
Publicado: (2021)

Metastatic Breast Cancer Masked as Constipation
por: McCray, Edwin, et al.
Publicado: (2021)

Preventing metastatic emergence of breast cancer
por: Wells, Alan, et al.
Publicado: (2021)

Liquid biopsy in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Should age impact breast cancer management in young women? Fine tuning of treatment guidelines
por: Suter, Matteo B., et al.
Publicado: (2018)

Metastatic Sigmoid Colon Malignancy With a Synchronous Carcinoma Breast: Is Cure Possible?
por: Gadiyaram, Srikanth, et al.
Publicado: (2022)

Lost but Not Least—Novel Insights into Progesterone Receptor Loss in Estrogen Receptor-Positive Breast Cancer
por: Kunc, Michał, et al.
Publicado: (2021)

Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort
por: Frank, Sophie, et al.
Publicado: (2020)

Progression-free survival and quality of life in metastatic breast cancer: The patient perspective
por: Mertz, Shirley, et al.
Publicado: (2022)

Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer
por: Al Zeyoudi, Jawaher, et al.
Publicado: (2021)

Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
por: Lamsal, Apsana, et al.
Publicado: (2023)

Inflammatory Breast Cancer from Metastatic Ovarian Cancer
por: Achariyapota, Vuthinun, et al.
Publicado: (2016)

Health state utilities for metastatic breast cancer
por: Lloyd, A, et al.
Publicado: (2006)

Weekly docetaxel in the treatment of metastatic breast cancer
por: Palmeri, Laura, et al.
Publicado: (2008)

Recent advances in treatment of metastatic breast cancer
por: Coleman, R
Publicado: (2010)

Eribulin mesylate in the treatment of metastatic breast cancer
por: Jain, Sarika, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jd5l8015led6mca7hhcit76c3f